| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Aspartame | Aspartame CRS (A1320000) | PVE0042 | View CAS 22839-47-0 |
| Aspartame | Aspartame EP Impurity A | VL280003 | View CAS 55102-13-1 |
| Aspartame | Aspartame EP Impurity B | VL280001 | View CAS 13433-09-5 |
| Aspartame | Aspartame EP Impurity C | VL280002 | View |
| Aspartame | Rac-Aspartame EP Impurity C | VL280004 | View CAS 150-30-1 |
| Catalogue No. | VL280001 |
| CAS No. | 13433-09-5 |
| Molecular Formula | C13H16N2O5 |
| Molecular Weight | 280.28 |
| Parent drug | Aspartame |
| IUPAC Name | L-aspartyl-L-phenylalanine |
| Synonyms | Aspartame Impurity B (L-aspartyl-L-phenylalanine) |
| References | Lean, Michael E. J., and Catherine R. Hankey. “Aspartame and Its Effects on Health.” BMJ, vol. 329, no. 7469, Sept. 2004, pp. 755–56, https://doi.org/10.1136/bmj.329.7469.755. |
| Status | In-stock |
| ListName | Aspartame EP Impurity B |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
